Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹30 Cr
Revenue (TTM)
₹16 Cr
Net Profit (TTM)
₹-4 Cr
ROE
-0.5 %
ROCE
-0.7 %
P/E Ratio
--
P/B Ratio
0.3
Industry P/E
48.17
EV/EBITDA
-10.6
Div. Yield
0 %
Debt to Equity
0
Book Value
₹92.9
EPS
₹-3.5
Face value
10
Shares outstanding
12,469,956
CFO
₹49.67 Cr
EBITDA
₹30.06 Cr
Net Profit
₹23.26 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medi-Caps
| -22.8 | -2.1 | -24.7 | -43.8 | -11.6 | -9.0 | 1.9 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Medi-Caps
| -36.1 | -3.4 | 7.8 | -5.1 | 107.6 | 100.9 | -15.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medi-Caps
|
24.1 | 30.1 | 16.0 | -4.4 | -58.4 | -3.7 | -- | 0.3 |
| 2,791.2 | 34,954.5 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.5 | 7.6 | |
| 1,547.6 | 29,369.3 | 8,850.1 | 894.8 | 15.2 | 19.8 | 33.8 | 5.9 | |
| 1,249.1 | 5,427.3 | 6,020.3 | 132.1 | 3.2 | 6.8 | 48.1 | 3.0 | |
| 1,961.1 | 31,488.0 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.8 | 7.9 | |
| 30.5 | 13.4 | 25.3 | 0.1 | 0.4 | 2.5 | 117.7 | 2.8 | |
| 33.1 | 20.7 | 4.6 | 0.4 | 1.7 | 4 | 53.2 | 2.1 | |
| 43.5 | 23.8 | 294.6 | 2.1 | 0.9 | 163.8 | 11.6 | 9.3 | |
| 1.9 | 7.6 | 110.0 | -0.2 | 0.0 | -3.5 | -- | 1.6 | |
| 0.3 | 30.9 | 386.8 | 35.4 | 11.1 | 29.9 | 0.9 | 0.2 |
No Review & Analysis are available.
Medi-Caps Limited manufactures and sells empty hard gelatin capsule shells in India. It offers halal gelatin, liquid fill, sodium lauryl sulfate free, and preservative free capsules. The company was incorporated in 1983 and is based in Indore, India.
Incorporated
1983
Chairman
Ramesh Chandra Mittal
Managing Director
Alok K Garg
Headquarters
Indore, Madhya Pradesh
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Medi-Caps Ltd is ₹24.10 (BSE) as of 02-Apr-2026 IST. Medi-Caps Ltd has given a return of -11.64% in the last 3 years.
Since, TTM earnings of Medi-Caps Ltd is negative, P/E ratio is not available.
The P/B ratio of Medi-Caps Ltd is 0.26 times as on 02-Apr-2026, a 0 premium to its peers’ median range of 0.26 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.43
|
|
2024
|
0.00
|
0.46
|
|
2023
|
24.81
|
0.37
|
|
2022
|
6.14
|
0.53
|
|
2021
|
4.52
|
0.48
|
The 52-week high and low of Medi-Caps Ltd are Rs 47.20 and Rs 21.00 as of 02-Apr-2026.
Medi-Caps Ltd has a market capitalisation of ₹ 30 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Medi-Caps Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.41
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.